SHIFTY MEDICINE: Kayexalate is a potentially harmful therapy to treat hyperkalemia

Kayexalate is a potentially harmful therapy to treat hyperkalemia, it has a slow onset action (if at all) and doubtful efficacy. It also carries risk of life threatening gastrointestinal complications. There is NO CONVINCING EVIDENCE that Kayexalate increases fecal potassium losses.

EMKF

The Emergency Medicine Kenya (EMK) Foundation is a not-for-profit organization registered in Kenya in 2015 that aims to ensure timely, accessible and quality lifesaving emergency care in Kenya.